Gabelli Global Small & Mid Cap Value Trust 8-K

What Happened

• The fund filed an 8-K (May 7, 2026) disclosing that Mario J. Gabelli — Trustee, Chairman and Chief Investment Officer of the Fund — was admitted to the hospital for observation and testing after a medical incident on March 19, 2026. His condition is improving, but no return date has been given.
• In accordance with a long‑standing succession plan, GAMCO (the parent of the Fund’s adviser, Gabelli Funds, LLC) implemented its plan on March 22, 2026 and named Christopher J. Marangi President of GAMCO. Day‑to‑day operations of GAMCO will be led by co‑CEO Douglas R. Jamieson and Christopher J. Marangi.
• The fund’s portfolio management will be led during Mr. Gabelli’s absence by the Gabelli Value team Co‑Chief Investment Officers Kevin V. Dreyer and Christopher J. Marangi.

Key Details

• Filing date: Form 8‑K filed May 7, 2026.
• Medical incident: Mr. Gabelli experienced an incident on March 19, 2026 and was admitted for observation; condition improving; timeline for return unknown.
• Succession action: GAMCO implemented its succession plan on March 22, 2026 and named Christopher J. Marangi President; Douglas R. Jamieson and Marangi to run day‑to‑day operations.
• Portfolio leadership: Kevin V. Dreyer and Christopher J. Marangi appointed to lead portfolio management for the Fund during Gabelli’s absence.

Why It Matters

• For investors, this notice confirms a temporary leadership change at the adviser level and shows a pre‑existing succession plan has been activated, which supports continuity of management and investment oversight.
• The filing does not announce any change to the Fund’s investment strategy or disclose financial impacts; portfolio management responsibility has been assigned to senior team members to minimize disruption.